Literature DB >> 20801447

Cytology versus visual inspection with acetic acid among women treated previously with cryotherapy in a low-resource setting.

Miriam Cremer1, Kimberley Bullard, Mauricio Maza, Ethel Peralta, Elizabeth Moore, Lydia Garcia, Rachel Masch, Veronica Lerner, Todd A Alonzo, Juan Felix.   

Abstract

OBJECTIVE: To compare visual inspection with acetic acid (VIA) with conventional cervical cytology as a follow-up cervical cancer screening method in women who had been treated previously with cryotherapy.
METHODS: Salvadoran women screened with VIA and treated with cryotherapy within 3 years were eligible to participate. Study participants were rescreened with VIA, Pap smear, colposcopy, 4-quandrant biopsy, and endocervical curettage.
RESULTS: Of 147 women enrolled in the study, post-cryotherapy VIA was positive in 39 women (26.5%; 95% CI, 19.6%-34.4%). Of these 39, 1 woman had CIN 1 or higher on biopsy. Post-cryotherapy Pap smear was positive (ASCUS or higher) in 6 women (4.1%; 95% CI, 1.5%-8.7%). Of these 6, 2 women had CIN 1 or higher on biopsy. Post-cryotherapy specificity was significantly higher for Pap compared with VIA (95.8% [138/144]; 95% CI, 91.2%-98.5% vs 73.6% [106/144]; 95% CI, 65.6%-80.6%; P<0.001).
CONCLUSION: As the single-visit approach for cervical cancer screening gains popularity, more women will have been treated with cryotherapy. Appropriate follow-up screening is therefore vital. Cytology may be a more suitable screening method than VIA in low-resource settings for women treated previously with cryotherapy.
Copyright © 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20801447     DOI: 10.1016/j.ijgo.2010.06.022

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

1.  Cervical cancer screening in primary health care setting in Sudan: a comparative study of visual inspection with acetic acid and Pap smear.

Authors:  Ahmed Ibrahim; Arja R Aro; Vibeke Rasch; Eero Pukkala
Journal:  Int J Womens Health       Date:  2012-02-28

2.  Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Authors:  Nicole G Campos; Mercy Mvundura; Jose Jeronimo; Francesca Holme; Elisabeth Vodicka; Jane J Kim
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

3.  Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.

Authors:  Nicole G Campos; Vivien Tsu; Jose Jeronimo; Mercy Mvundura; Jane J Kim
Journal:  BMC Cancer       Date:  2017-11-25       Impact factor: 4.430

4.  To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.

Authors:  Nicole G Campos; Vivien Tsu; Jose Jeronimo; Mercy Mvundura; Kyueun Lee; Jane J Kim
Journal:  Int J Cancer       Date:  2017-03-15       Impact factor: 7.396

5.  Cervical cancer prevention in El Salvador (CAPE)-An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country.

Authors:  Mauricio Maza; Karla Alfaro; Jillian Garai; Mario Morales Velado; Julia C Gage; Philip E Castle; Juan Felix; Silvana Luciani; Nicole Campos; Jane Kim; Rachel Masch; Miriam Cremer
Journal:  Gynecol Oncol Rep       Date:  2017-03-03

6.  The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.

Authors:  Nicole G Campos; Mauricio Maza; Karla Alfaro; Julia C Gage; Philip E Castle; Juan C Felix; Rachel Masch; Miriam Cremer; Jane J Kim
Journal:  Int J Gynaecol Obstet       Date:  2019-04       Impact factor: 3.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.